A new blood-based genetic test might predict the presence of dangerous BRCA1 or BRCA2 gene mutations in women, according to a study published in the January 22 issue of Cancer Prevention Research.

Atossa Genetics developing diagnostic and therapeutic system in effort to curb trend.